Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer

Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Hui, Nan, Manman, Li, Yizhen, Ding, Yi, Yin, Yuhui, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067930/
https://www.ncbi.nlm.nih.gov/pubmed/37020597
http://dx.doi.org/10.3389/fendo.2023.1148412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067930/
https://www.ncbi.nlm.nih.gov/pubmed/37020597
http://dx.doi.org/10.3389/fendo.2023.1148412

Ejemplares similares